Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.34014 | 53 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.25155 | 52 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.26356 | 52 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.06931 | 48 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.10319 | 49 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.45061 | 54 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.48735 | 56 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.26613 | 52 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.21196 | 51 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.27028 | 53 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.27731 | 53 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.26146 | 53 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.27517 | 52 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.2724 | 52 |